These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 26438628)

  • 1. In Vitro and In Vivo Mechanistic Studies toward Understanding the Role of 1-Aminobenzotriazole in Rat Drug-Drug Interactions.
    Boily MO; Chauret N; Laterreur J; Leblond FA; Boudreau C; Duquet MC; Lévesque JF; Ste-Marie L; Pichette V
    Drug Metab Dispos; 2015 Dec; 43(12):1960-5. PubMed ID: 26438628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1-Aminobenzotriazole modulates oral drug pharmacokinetics through cytochrome P450 inhibition and delay of gastric emptying in rats.
    Stringer RA; Weber E; Tigani B; Lavan P; Medhurst S; Sohal B
    Drug Metab Dispos; 2014 Jul; 42(7):1117-24. PubMed ID: 24727486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of pretreatment regimens of 1-aminobenzotriazole on metabolism and gastric emptying of probe compounds in rat.
    Padmanabhan S; Kaur H; Rao A; Saxena A; Gupta YK; Mariappan TT; Holenarsipur VK
    Xenobiotica; 2019 Jun; 49(6):646-654. PubMed ID: 29898636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo use of the P450 inactivator 1-aminobenzotriazole in the rat: varied dosing route to elucidate gut and liver contributions to first-pass and systemic clearance.
    Strelevitz TJ; Foti RS; Fisher MB
    J Pharm Sci; 2006 Jun; 95(6):1334-41. PubMed ID: 16625658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo characterization of CYP inhibition by 1-aminobenzotriazole in rats.
    Parrish KE; Mao J; Chen J; Jaochico A; Ly J; Ho Q; Mukadam S; Wright M
    Biopharm Drug Dispos; 2016 May; 37(4):200-11. PubMed ID: 26637499
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1-Aminobenzotriazole, a known cytochrome P450 inhibitor, is a substrate and inhibitor of N-acetyltransferase.
    Sun Q; Harper TW; Dierks EA; Zhang L; Chang S; Rodrigues AD; Marathe P
    Drug Metab Dispos; 2011 Sep; 39(9):1674-9. PubMed ID: 21677062
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of the suicide CYP450 inhibitor ABT for distinguishing absorption and metabolism processes in in-vivo pharmacokinetic screens.
    Caldwell GW; Ritchie DM; Masucci JA; Hageman W; Cotto C; Hall J; Hasting B; Jones W
    Eur J Drug Metab Pharmacokinet; 2005; 30(1-2):75-83. PubMed ID: 16010865
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of drug metabolism in rat liver slices: IV. Comparison of ethoxycoumarin clearance by liver slices, isolated hepatocytes, and hepatic microsomes from rats pretreated with known modifiers of cytochrome P-450 activity.
    Carlile DJ; Hakooz N; Houston JB
    Drug Metab Dispos; 1999 Apr; 27(4):526-32. PubMed ID: 10101148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-Aminobenzotriazole-induced destruction of hepatic and renal cytochromes P450 in male Sprague-Dawley rats.
    Mugford CA; Mortillo M; Mico BA; Tarloff JB
    Fundam Appl Toxicol; 1992 Jul; 19(1):43-9. PubMed ID: 1397800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating the Disposition of a Mixed Aldehyde Oxidase/Cytochrome P450 Substrate in Rats with Attenuated P450 Activity.
    Crouch RD; Morrison RD; Byers FW; Lindsley CW; Emmitte KA; Daniels JS
    Drug Metab Dispos; 2016 Aug; 44(8):1296-303. PubMed ID: 26936972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolism of the cytochrome P450 mechanism-based inhibitor N-benzyl-1-aminobenzotriazole to products that covalently bind with protein in guinea pig liver and lung microsomes: comparative study with 1-aminobenzotriazole.
    Woodcroft KJ; Webb CD; Yao M; Weedon AC; Bend JR
    Chem Res Toxicol; 1997 May; 10(5):589-99. PubMed ID: 9168258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of food pellets containing 1-aminobenzotriazole for longer term in vivo inhibition of cytochrome P450 in mice.
    Stringer R; Cordier V; Afatsawo C; Arabin P; Desrayaud S; Hoffmann L; Lehmann D; Lowe PJ; Risser F; Thiel J; Widmer T; Wipfli P; Bigaud M
    Xenobiotica; 2019 Jan; 49(1):13-21. PubMed ID: 29299977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of testicular steroid metabolism by administration of 1-aminobenzotriazole to rats.
    Soltis M; Colby HD
    Pharmacology; 1998 Jan; 56(1):51-6. PubMed ID: 9467188
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro and in vivo evaluation of the effect of puerarin on hepatic cytochrome p450-mediated drug metabolism.
    Kim SB; Yoon IS; Kim KS; Cho SJ; Kim YS; Cho HJ; Chung SJ; Chong S; Kim DD
    Planta Med; 2014 May; 80(7):561-7. PubMed ID: 24710899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1-Aminobenzotriazole coincubated with (S)-warfarin results in potent inactivation of CYP2C9.
    Sodhi JK; Ford KA; Mukadam S; Wong S; Hop CE; Khojasteh SC; Halladay JS
    Drug Metab Dispos; 2014 May; 42(5):813-7. PubMed ID: 24550229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of adrenal cytochromes P450 by 1-aminobenzotriazole. Divergence of in vivo and in vitro actions.
    Colby HD; Abbott B; Cachovic M; Debolt KM; Mico BA
    Biochem Pharmacol; 1995 Apr; 49(8):1057-62. PubMed ID: 7748185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effective dosing regimen of 1-aminobenzotriazole for inhibition of antipyrine clearance in rats, dogs, and monkeys.
    Balani SK; Zhu T; Yang TJ; Liu Z; He B; Lee FW
    Drug Metab Dispos; 2002 Oct; 30(10):1059-62. PubMed ID: 12228180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An in vitro digestion test that reflects rat intestinal conditions to probe the importance of formulation digestion vs first pass metabolism in Danazol bioavailability from lipid based formulations.
    Anby MU; Nguyen TH; Yeap YY; Feeney OM; Williams HD; Benameur H; Pouton CW; Porter CJ
    Mol Pharm; 2014 Nov; 11(11):4069-83. PubMed ID: 25265395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic interaction between metoprolol and SP-8203 in rats: competitive inhibition for the metabolism of metoprolol by SP-8203 via hepatic CYP2D subfamily.
    Han SY; Yoon I; Chin YW; Cho IW; Lee MG; Choi YH
    Xenobiotica; 2012 Oct; 42(10):1017-27. PubMed ID: 22568632
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of oxygen-induced lung injury in rats by the mechanism-based cytochrome P-450 inhibitor, 1-aminobenzotriazole.
    Moorthy B; Parker KM; Smith CV; Bend JR; Welty SE
    J Pharmacol Exp Ther; 2000 Feb; 292(2):553-60. PubMed ID: 10640292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.